This is the authors' abstract. We don't add key points for this paper.
Background: ) mutation, and oxygen 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in patients with diffuse gliomas. Methods: test were used for assessing the statistical differences in patients' clinical characteristics. Delong test was performed to compare the areas under the curve (AUCs) of different radiomics models. Results: For WHO Grade task, the combined model of structural MRI, ADC, and SWI achieved the highest AUC of 0.951 [95% confidence interval (CI): 0.886-1.000] on the external test cohort. For IDH mutation task, the structural MRI model achieved the highest AUC of 0.917 (95% CI: 0.801-1.000) on the external test cohort. For MGMT task, the combined model of structural MRI and ADC achieved the highest AUC of 0.650 (95% CI: 0.485-0.814) on the internal validation cohort. Conclusions: mutation.
No takes yet. Share an insight, caveat, or question.
Zhu et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: